Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2013, Vol. 33 Issue (1): 14-19    DOI:
    
The Constructing and Purification of Recombinant Human Fibroblast Growth Factor 8b Expressed Vector
HUANG Peng-huang1,2,3, WANG Ze1,2,3, TIAN Hai-shan2,4, ZHAO Hai-yang2, LI Hai-yan1,3, LI Xiao-kun1,2,4
1. ME Engineering Research Center of Bioreactor and Pharmaceutical Development, Jilin Agriculture University, Changchun 130021, China;
2. School of Pharmacy, Wenzhou Medical College, Wenzhou 325035, China;
3. School of Life Science, Jilin Agriculture University, Changchun 130021, China;
4. Zhejiang Gelusite Biology Technology Co. Ltd., Wenzhou 325000, China
Download: HTML   PDF(575KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  FGF8b, which belongs to the fibroblast growth factor family, has been found to be associated with the regulation of growth and progression of hormonal cancers. Thus, it is believed that FGF8b could be a potential target in the treatment of hormonal cancers. To improve the production of recombinant hFGF8b to meet the increasing demand in basic research and clinical applications, an artificial gene encoding its mature peptide sequence was constructed and cloned into vector pET-3a. Then the recombinant proteins were expressed and presented in form of inclusion bodies in Escherichia coli BL21(DE3)pLysS. Expression, purification and renaturation conditions of the recombinant proteins were optimized. The preliminary biochemical characterization of FGF8b was further confirmed by Western blotting, and its mitogen activity was tested through MTT assay. In summary, this study has successfully acquired active recombinant FGF8b protein, which can be used for the further clinical development of embryology and the basic hormonal cancer researches.

Key wordsFibroblast growth factor 8b      Refolding      Inclusion body     
Received: 18 October 2012      Published: 25 January 2013
ZTFLH:  Q78  
Cite this article:

HUANG Peng-huang, WANG Ze, TIAN Hai-shan, ZHAO Hai-yang, LI Hai-yan, LI Xiao-kun. The Constructing and Purification of Recombinant Human Fibroblast Growth Factor 8b Expressed Vector. China Biotechnology, 2013, 33(1): 14-19.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2013/V33/I1/14

[1] Tanaka A, Miyamoto K, Minamino N, et al. Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells. Proc Natl Aead Sei USA, 1992, 89:8928-8932.
[2] Gemel J, Gorry M, Ehrlich G D, et al. Structure and sequence of human FGF8. Genomics, 1996, 35(5):253-257.
[3] Ornitz D M, Xu J, Colvin J S, et al. Receptor specificity of the fibroblast growth factor family. BiolChem 1996, 271(25):15292-15297.
[4] Crossley P H, Martin G R. The mouse Fgf8 gene encodes a family of polypeptides and is expressed in regions that direct out growth and patterning in the developing embryo. Development, 1995, 121:439-451.
[5] Sun X, Meyers E N, Lewandoski M, et al. Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo.Genes Dev, 1999, 13:1834-1846.
[6] Ohuchi H, Yoshioka H, Tanaka A, et al. Involvement of androgen-induced growth factor(FGF-8)gene in mouse embryogenesis and morphogenesis. Biochem Biophys ResCommun, 1994, 204(2):882-888.
[7] Heikinheimo M, Lawshe A, Shackleford G M, et al. Fgf-8 expression in the post-gastrulation mouse suggests roles in the development of the face, limbs and central nervous system. Mech Dev, 1994, 48(2):129-138.
[8] Haraguchi R, Suzuki K, Murakami R, et al. Molecular analysis of external genitalia formation:the role of fibroblast growth factor(Fgf)genes during genital tubercle formation. Development, 2000, 127(11):2471-2479.
[9] Crossley P H, Minowada G, MacArthur C A, et al. Roles for FGF8 in the induction, initiation, and maintenance of chick limb development. Cell, 1996, 84(1):127-136.
[10] Crossley P H, Martinez S, Martin G R. Midbrain development induced by FGF8 in the chick embryo. Nature, 1996, 380(6569):66-68.
[11] Daphna-Iken D, Shankar D B, Lawshe A, et al. MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia. Oncogene, 1998, 17(21):2711-2717.
[12] Zhong C, Saribekyan G, Liao C, et al. Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis. Cancer Res, 2006, 66(4):2188-2194.
[13] Dorkin T J, Robinson M C, Marsh C, et al. aFGF immunoreactivity in prostate cancer and its co-localization with bFGF and FGF8. J Pathol, 1999, 189(4):564-569.
[14] Kwabi-Addo B, Ozen M, Ittmann M. The role of fibroblast growth factors and their receptors in prostate cancer. Endocr Relat Cancer, 2004, 11(4):709-724.
[15] Tanaka A, Kamiakito T, Takayashiki N, et al. Fibroblast growth factor 8 expression in breast carcinoma:associations with androgen receptor and prostate-specific antigen expressions. Virchows Arch, 2002, 441(4):380-384.
[16] Somboonporn W, Davis S R. Testosterone effects on the breast:implications for testosterone therapy for women. Endocr Rev, 2004, 25(3):374-388.
[17] Valve E, Martikainen P, Seppanen J, et al. Expression of fibroblast growth factor(FGF)-8 isoforms and FGF receptors in human ovarian tumors. Int J Cancer, 2000, 88(5):718-725.
[18] Olsen S K, Li J Y, Bromleigh C, et al. Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain.Genes Dev. 2006, 15;20(2):185-198.
[19] Goetz R, Ohnishi M, Ding X, et al. Klotho coreceptors inhibit signaling by paracrine fibroblast growth factor 8 subfamily ligands.Mol Cell Biol. 2012, 32(10):1944-1954.
[20] Mayer M, Buchner J. Refolding of inclusion body proteins. Methods Mol Med, 2004, 94: 239-254.
[21] Burgess R R. Refolding solubilized inclusion body proteins. Methods Enzymol. 2009, 463: 259-282.
[1] XUE Ling, LIU Jiang-ning, ZHANG Yao, ZHANG Chun, WANG Qi, QIN Chuan, LIU Yong-dong, SU Zhi-guo. Affinity Purification of Enterovirus 71 Fused Multi-Epitope Protein Antigen and Assembling It as Virus-like Particles in Vitro[J]. China Biotechnology, 2016, 36(7): 34-40.
[2] GAO Wen, GAO Xiang-dong, LU Xiao-dong, XU Chen. Liquid Chromatographic Refolding of Proteins and Process Evaluation[J]. China Biotechnology, 2015, 35(3): 84-91.
[3] SU Yan-nan, XUE Zheng-lian, CHEN Tao, MA Qi-ya. The Optimized Phospholipase A1 Gene Expression of Serratia marcescens PL-06 in E. coli[J]. China Biotechnology, 2013, 33(7): 36-42.
[4] LI Qian-qian, LI Zhong-yuan, FENG Duo, HUANG Huo-qing, HAN Cui-xiao, YANG Pei-long, YAO Bin, GAO Wei. Optimizing Soluble Expression and Inclusion Body Renature Research of β-Propeller Phytase of Bacillus sp. HJB17 in E.coli[J]. China Biotechnology, 2012, 32(08): 49-55.
[5] WANG Zhen-dong, WANG Lin-lin, YANG Yu, YANG Yong-li, WANG Jing. Preparation and Purification of the Recombinant Protein of Venezuelan Equine Encephalitis Virus and Construction of GICA Method[J]. China Biotechnology, 2011, 31(7): 104-108.
[6] LI Wei. Expression, Purification and Characterization of the Zinc Finger Domain of PLZF Protein[J]. China Biotechnology, 2011, 31(11): 1-5.
[7] LIU Xiao-fei, PEI Jian-zhu, DU Guo-jun, YANG Zhang-min. Recent Progress in Renaturation of Inclusion Bodies of Prokaryotically Expressed Snake Venom Proteins[J]. China Biotechnology, 2011, 31(03): 113-119.
[8] HUI Wei-Wei, DIAO Jian, WANG Zhen-Hu, JIA Tian. Expression of Chitinase Gene of HaSNPV, and Purification,Refolding of Its Recombinant Protein[J]. China Biotechnology, 2010, 30(02): 77-82.
[9] HUANG Zhi-Feng, YANG Shu-Lin, NI Chun-Yan, ZHANG Yi, ZHOU Xiang-Tian, LI Jiao-Kun. Study of pH-responsive Polymer-assisted TGF-β1 Refolding[J]. China Biotechnology, 2009, 29(08): 26-32.
[10] . Construction and expression of C3-BPI fusion protein (CB) in E. coli[J]. China Biotechnology, 2007, 27(6): 31-37.
[11] . Site-directed mutagenesis and enzymatic activity assay of Gln49-Phospholipase A2 mutant[J]. China Biotechnology, 2007, 27(5): 21-27.
[12] . Construction of Prokaryotic Expression Vector for Soluble HLA-A*0203-BSP and Its High Yield Expression in Escherichia coli[J]. China Biotechnology, 2006, 26(09): 5-10.